Compounds > quinoxalines

Page last updated: 2024-08-17

quinoxalines and Koch's Disease

quinoxalines has been researched along with Koch's Disease in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (8.33)	29.6817
2010's	11 (91.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Budagumpi, S; Keri, RS; Nagaraja, BM; Pandule, SS	1
Abbadi, BL; Barbosa Junior, F; Basso, LA; Bergo, PF; Campos, MM; Carrão, DB; da Silva, JB; de Albuquerque, NCP; de Freitas, TF; de Oliveira, ARM; Fachini, J; Habenschus, MD; Macchi, FS; Mascarello, A; Morbidoni, HR; Muradás, TC; Neuenfeldf, P; Norberto de Souza, O; Nunes, RJ; Picada, JN; Rocha, BA; Rodrigues-Junior, VS; Sperotto, NDM; Timmers, LFSM; Villela, AD	1
Aldana, I; Ancizu, S; Burguete, A; Monge, A; Moreno, E; Pérez-Silanes, S; Solano, B; Torres, E; Villar, R	1
Castro, EA; Duchowicz, PR; Monge, A; Ortiz, Edel V; Vicente, E	1
Aldana, I; Ancizu, S; Monge, A; Moreno, E; Pérez-Silanes, S; Torres, E	1
Costa, BP; Costa-Filho, AJ; Gambino, D; Leite, CQ; Mercader, RC; Monge, A; Pavan, FR; Ribeiro, RR; Tarallo, MB; Torre, MH; Urquiola, C	1
Bandy, B; Das, S; Das, U; Dimmock, JR; Gorecki, DK	1
Goldman, RC	1
Aldana, I; Gabano, E; Monge, A; Moreno, E; Pérez-Silanes, S; Platts, JA; Ravera, M; Torres, E	1
Chopra, S; Doppalapudi, RS; Franzblau, SG; Green, CE; Iyer, LV; Koolpe, GA; Madrid, PB; Matsuyama, KN; Riccio, ES; Ryan, KJ; Tambo-Ong, AA; Tran, TB; Wan, B	1
Aldana, I; Cho, SH; Franzblau, SG; Goldman, RC; Lenaerts, AJ; Maddry, JA; Monge, A; Pérez-Silanes, S; Solano, B; Vicente, E; Villar, R	1

Reviews

1 review(s) available for quinoxalines and Koch's Disease

Article	Year
Quinoxaline and quinoxaline-1,4-di-N-oxides: An emerging class of antimycobacterials. Archiv der Pharmazie, 2018, Volume: 351, Issue:5 Topics: Antitubercular Agents; Drug Design; Humans; Oxides; Quinoxalines; Structure-Activity Relationship; Tuberculosis	2018

Other Studies

11 other study(ies) available for quinoxalines and Koch's Disease

Article	Year
Pre-clinical evaluation of quinoxaline-derived chalcones in tuberculosis. PloS one, 2018, Volume: 13, Issue:8 Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Chalcones; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Mycolic Acids; Oxidoreductases; Quinoxalines; Tuberculosis	2018
Public health round-up. Bulletin of the World Health Organization, 2019, Jan-01, Volume: 97, Issue:1 Topics: Adenosine Monophosphate; Alanine; Aminoisobutyric Acids; Anti-Bacterial Agents; Antibodies, Monoclonal; Benzimidazoles; Cyclopropanes; Democratic Republic of the Congo; Disease Outbreaks; Drug Resistance, Bacterial; Global Health; Hemorrhagic Fever, Ebola; Hepatitis C; Humans; Interinstitutional Relations; Lactams, Macrocyclic; Leucine; Malaria; Measles; Measles Vaccine; Poliomyelitis; Proline; Public Health Practice; Pyrrolidines; Quinoxalines; Randomized Controlled Trials as Topic; Ribonucleotides; Sulfonamides; Tuberculosis	2019
New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents. Bioorganic & medicinal chemistry, 2010, Apr-01, Volume: 18, Issue:7 Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, Thin Layer; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinoxalines; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Tuberculosis; Vero Cells	2010
Exploring 3-arylquinoxaline-2-carbonitrile 1,4-di-N-oxides activities against neglected diseases with QSAR. Chemical biology & drug design, 2010, Volume: 76, Issue:1 Topics: Antimalarials; Antitubercular Agents; Humans; Linear Models; Malaria; Models, Biological; Mycobacterium tuberculosis; Oxides; Plasmodium falciparum; Quantitative Structure-Activity Relationship; Quinoxalines; Tuberculosis	2010
Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives. European journal of medicinal chemistry, 2010, Volume: 45, Issue:10 Topics: Amides; Animals; Antitubercular Agents; Cell Survival; Chlorocebus aethiops; Humans; Mycobacterium tuberculosis; Oxides; Quinoxalines; Tuberculosis; Vero Cells	2010
Design of novel iron compounds as potential therapeutic agents against tuberculosis. Journal of inorganic biochemistry, 2010, Volume: 104, Issue:11 Topics: Animals; Antitubercular Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Electrochemistry; Electron Spin Resonance Spectroscopy; Ferrous Compounds; Inhibitory Concentration 50; Iron Compounds; Ligands; Metals; Mice; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Quinoxalines; Tuberculosis	2010
E-2-[3-(3,4-dichlorophenyl)-1-oxo-2-propenyl]-3-methylquinoxaline-1,4-dioxide: a lead antitubercular agent which alters mitochondrial respiration in rat liver. European journal of medicinal chemistry, 2010, Volume: 45, Issue:10 Topics: Animals; Antitubercular Agents; Cell Respiration; Humans; Microbial Sensitivity Tests; Mitochondria, Liver; Mycobacterium tuberculosis; Oxides; Quinoxalines; Rats; Structure-Activity Relationship; Tuberculosis	2010
Maximizing bactericidal activity with combinations of bioreduced drugs. Future medicinal chemistry, 2010, Volume: 2, Issue:8 Topics: Animals; Antitubercular Agents; Clinical Trials as Topic; Drug Combinations; Drug Discovery; Free Radicals; Humans; Mycobacterium tuberculosis; Nitrofurans; Nitroimidazoles; Oxidation-Reduction; Quinoxalines; Tuberculosis	2010
Studies on log Po/w of quinoxaline di-N-oxides: a comparison of RP-HPLC experimental and predictive approaches. Molecules (Basel, Switzerland), 2011, Sep-13, Volume: 16, Issue:9 Topics: Chromatography, High Pressure Liquid; Cyclic N-Oxides; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quantitative Structure-Activity Relationship; Quinolines; Quinoxalines; Tuberculosis	2011
Discovery and optimization of benzotriazine di-N-oxides targeting replicating and nonreplicating Mycobacterium tuberculosis. Journal of medicinal chemistry, 2012, Jul-12, Volume: 55, Issue:13 Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Discovery; Female; Isomerism; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrofurans; Nitroimidazoles; Oxides; Quinoxalines; Rats; Tirapazamine; Triazines; Tuberculosis; Vero Cells	2012
In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide. The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:3 Topics: Administration, Oral; Animals; Antitubercular Agents; Biotransformation; Drug Resistance, Multiple, Bacterial; Female; Mice; Microbial Sensitivity Tests; Microbial Viability; Molecular Structure; Mycobacterium tuberculosis; Quinoxalines; Tuberculosis; Tuberculosis, Multidrug-Resistant	2008